START / NEWS

Prof. Dr. Frank Lohr confirms study results on PatLog™

April 2, 2012

Prof. Dr. Frank Lohr (University Medical Center Mannheim) confirms study results that show high reproducibility and accuracy for all treatment areas at the setup outside the treatment room and during transportation with ONCOlog Medical´s PatLog solution. Go to statement

Jens Aldag Key Account Manager DACH at ONCOlog Medical AB

January 2, 2012

Jens Aldag has been appointed Key Account Manager for D-A-CH (Germany, Austria and Switzerland) at ONCOlog Medical from January 1st, 2012.

Per Lundqvist appointed CEO at ONCOlog Medical AB

December 22, 2011

Göran Beijer has stepped down as CEO for ONCOlog Medical QA AB from December 19th and Per Lundqvist has been appointed new CEO. For more information contact Per Lundqvist, e-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it. , phone: +46 733164904, or Stefan Sallerfors, e-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it. , phone: +46 705907080.

Henrik Pelsenius Nordic Key Account Manager at ONCOlog Medical AB

September 26, 2011

Henrik Pelsenius has been appointed Nordic Key Account Manager at ONCOlog Medical from September 5th, 2011.

University Hospital, Umeå (Sweden) and ONCOlog Medical sign an agreement to evaluate the benefits of the PatLog™ patient logistics solution.

June 17, 2011
 
ONCOlog Medical AB and the University Hospital in Umeå, in the North of Sweden, have signed an agreement to study the benefits of PatLog™, a patient logistics solution, in one of their treatment rooms at the new clinic.
 
The purpose is to identify improvements in workflow and patient experience by PatLog before, during and after treatment in external radiotherapy.
 
The PatLog™ patient logistics solution consists of unique tools for immobilization of radiotherapy patients on the treatment table plate with a reclining device outside the treatment room and thereafter transporting the patients in treatment position on an auto-controlled carrier into the treatment room.
 
The PatLog™ patient logistics solution has been developed in its first application for proton therapy in co-operation with the Belgian company IBA (Ion Beam Applications) but is also applicable for traditional radiotherapy with linear accelerators. PatLog has been installed in Essen at WPE and will be installed in Prague, Dimitrovgrad and in the Skandion clinic.

 

ONCOlog Medical QA AB
Vallvägen 4B, SE-756 51, Uppsala, Sweden
PHONE: +46 18-19 45 65
FAX: +46 18-30 06 85
E-MAIL: This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

 

 

 

CE Notified Body DGM, Denmark 0543 I ISO 13485:2003 International Standard specifies the quality system requirements for the design/development, production and, when relevant, installation and servicing of medical devices. CE Certificate Council Directive 93/42/EEC, Annex II, Section 3.2. Medical Device Directive. FDA. PatLog 1.0 FDA cleared 1/23/2009 K090044. PatLog 2.0 FDA cleared 10/9/2009 K092939. ONCOlog Medical registered for sale in the Russian territory.